MW 852.1 Da, Purity >98%. Potent, selective vacuolar type H+-ATPase inhibitor. Antibiotic agent. Induces EGF-dependent apoptosis. Shows similar effects as Concanamycin A (ab144227) and Concanamycin C (ab144229). Shows potent antiviral effects (IC50 = 6 nM, HSV-1 replication).
MW 852.1 Da, Purity >98%. Potent, selective vacuolar type H+-ATPase inhibitor. Antibiotic agent. Induces EGF-dependent apoptosis. Shows similar effects as Concanamycin A (ab144227) and Concanamycin C (ab144229). Shows potent antiviral effects (IC50 = 6 nM, HSV-1 replication).
Soluble in DMSO.
Potent, selective vacuolar type H+-ATPase inhibitor. Antibiotic agent. Induces EGF-dependent apoptosis. Shows similar effects as Concanamycin A (ab144227) and Concanamycin C (ab144229). Shows potent antiviral effects (IC50 = 6 nM, HSV-1 replication).
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
2D chemical structure image of ab144228, Concanamycin B, H+-ATPase inhibitor
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com